Get the Stockscreener App
3.90
3.23%
-0.13
After Hours:
4.00
0.10
+2.56%
Quoin Pharmaceuticals Ltd Adr stock is traded at $3.90, with a volume of 31,569.
It is down -3.23% in the last 24 hours and down -43.48% over the past month.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
See More
Previous Close:
$4.03
Open:
$4
24h Volume:
31,569
Relative Volume:
0.58
Market Cap:
$7.83M
Revenue:
Net Income/Loss:
$-17.10M
P/E Ratio:
-0.0165
EPS:
-236.7281
Net Cash Flow:
$-15.92M
1W Performance:
-13.33%
1M Performance:
-43.48%
6M Performance:
-40.73%
1Y Performance:
-71.20%
1-Day Range:
$3.90
$4.11
1-Week Range:
$3.90
$5.31
52-Week Range:
$3.25
$23.50
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Name
Quoin Pharmaceuticals Ltd Adr
Sector
Industry
Phone
97299741444
Address
23 HATA'AS STREET, KFAR SABA
Compare QNRX vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
3.90 | 7.83M | 0 | -17.10M | -15.92M | -236.73 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-12-26 | Initiated | BTIG Research | Buy |
| Sep-23-26 | Initiated | Lake Street | Buy |
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News
Two parties report a passive stake in Quoin Pharmaceuticals (QNRX), covering 211,538 depositary shares. - Stock Titan
Quoin Pharmaceuticals (QNRX) Climbs 3.51% to $4.72 as Shares Sit Near Mid-Range LevelsUpthrust Pattern - https://www.dars.gov.et/
Quoin registers 9.37M depositary shares for resale - Stock Titan
Shareholders in Quoin (QNRX) face vote on letting warrant holders own more and gain extra voting power - Stock Titan
Potential dilution looms as Quoin (NASDAQ: QNRX) registers ADS resales tied to warrant exercises - stocktitan.net
A doctor met a critically ill baby in the ICU, then adopted her - Stock Titan
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases - Investing.com India
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases - Investing.com
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs By Investing.com - Investing.com UK
Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases By Investing.com - Investing.com Australia
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs - Investing.com
Quoin Pharmaceuticals director Culverwell buys $29,992 in ADSs - Investing.com
Quoin Pharmaceuticals CFO Lawlor buys $49,990 in company stock - Investing.com
Quoin Pharmaceuticals CEO Michael Myers buys $99,991 ADSs - Investing.com India
Quoin Pharmaceuticals COO Denise Carter buys $99,991 in ADSs By Investing.com - Investing.com UK
Quoin Pharmaceuticals director Culverwell buys $29,992 in ADSs By Investing.com - Investing.com India
Quoin Pharmaceuticals CFO Lawlor buys $49,990 in company stock - Investing.com India
Quoin Pharmaceuticals (QNRX) CEO buys more ADSs with attached warrants - Stock Titan
Quoin Pharmaceuticals (QNRX) insider adds ADSs and warrants in private placement - Stock Titan
Dow Gains 100 Points; Chicago PMI Falls In August - Sahm
Quoin Pharmaceuticals Stock Surges Friday: What's Happening? - Sahm
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Dow Gains 100 Points; Chicago PMI Falls In August - Benzinga
Quoin Pharmaceuticals raises $30.8M in private placement - Investing.com
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million - Barchart.com
Quoin Pharmaceuticals Announces Up to $50 Million Private Placement Financing to Support QRX003 Development - Quiver Quantitative
Quoin Pharmaceuticals Secures Up to $50 Million to Advance Rare Disease Pipeline - citybiz
Quoin Pharma (QNRX) swaps $177,849 debt into director ADSs - Stock Titan
Quoin Pharma (NASDAQ: QNRX) director takes 31K ADSs for interest - Stock Titan
Dow rises 100 points as Chicago PMI misses estimates in August - scanx.trade
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading - careplusvn.com
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading - siam.in
Quoin (QNRX) Update: Rises 7.12% to $5.57 in the Latest Reading; $5.29 and $5.85 Define the Nearby Reference Levels in the Latest ReadingVolatility Smirk - dars.gov.et
Quoin Pharma (NASDAQ: QNRX) lifts board pay ceiling to $250K plus options - Stock Titan
Quoin Pharmaceuticals | 10-Q: Q2 2026 Earnings Report - Moomoo
Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results - Barchart.com
Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026 - Barchart.com
Cash flow from investing activities of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Cash flow from financing activities of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Book value per share of Quoin Pharmaceuticals. Ltd Sponsored ADR – LS:A41BEM - TradingView
Average basic shares outstanding of Quoin Pharmaceuticals. Ltd Sponsored ADR – LSX:A41BEM - TradingView
Quoin Pharmaceuticals (QNRX) Slightly Declines as Stock Tests Support Near $3.95Bollinger Band - careplusvn.com
Quoin Pharmaceuticals (QNRX) Slightly Declines as Stock Tests Support Near $3.95MESA MA - dars.gov.et
Insider Traders Lose US$65k As Quoin Pharmaceuticals Drops - Sahm
Price to earnings forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
Price to book forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
Enterprise value to EBIT forward of Quoin Pharmaceuticals. Ltd Sponsored ADR – FWB:2EB0 - TradingView
QNRX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Share Price UptickDividend Increase Stocks - careplusvn.com
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Sahm
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Myers Michael | Chief Executive Officer |
Aug 31 '26 |
Buy |
4.88 |
20,490 |
99,991 |
37,713 |
| Lawlor Sally Bridget | Chief Financial Officer |
Aug 31 '26 |
Buy |
4.88 |
10,244 |
49,991 |
10,684 |
| Culverwell Anthony James | Director |
Aug 31 '26 |
Buy |
4.88 |
6,146 |
29,992 |
40,364 |
| LANGER DENNIS | Director |
Oct 14 '25 |
Buy |
8.49 |
15,152 |
128,640 |
15,153 |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):